CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 141623-141984 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T96431","span":{"begin":0,"end":361},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Cases were subclassified into primary myelofibrosis (PMF), n=4; refractory cytopenia with multilineage dysplasia, n=3; acute myeloid leukemia (AML) with myelodysplasia-related changes, n=3; refractory anemia with excess blasts-2, n=1; AML-not otherwise specified, n=1; therapy-related AML, n=1; blast phase of PMF, n=1; and chronic myelomonocytic leukemia, n=1."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T52","span":{"begin":0,"end":361},"obj":"Sentence"}],"text":"Cases were subclassified into primary myelofibrosis (PMF), n=4; refractory cytopenia with multilineage dysplasia, n=3; acute myeloid leukemia (AML) with myelodysplasia-related changes, n=3; refractory anemia with excess blasts-2, n=1; AML-not otherwise specified, n=1; therapy-related AML, n=1; blast phase of PMF, n=1; and chronic myelomonocytic leukemia, n=1."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T344","span":{"begin":38,"end":51},"obj":"Phenotype"},{"id":"T345","span":{"begin":119,"end":141},"obj":"Phenotype"},{"id":"T346","span":{"begin":143,"end":146},"obj":"Phenotype"},{"id":"T347","span":{"begin":153,"end":167},"obj":"Phenotype"},{"id":"T348","span":{"begin":190,"end":207},"obj":"Phenotype"},{"id":"T349","span":{"begin":235,"end":238},"obj":"Phenotype"},{"id":"T350","span":{"begin":285,"end":288},"obj":"Phenotype"},{"id":"T351","span":{"begin":324,"end":355},"obj":"Phenotype"}],"attributes":[{"id":"A344","pred":"hp_id","subj":"T344","obj":"http://purl.obolibrary.org/obo/HP_0011974"},{"id":"A345","pred":"hp_id","subj":"T345","obj":"http://purl.obolibrary.org/obo/HP_0004808"},{"id":"A346","pred":"hp_id","subj":"T346","obj":"http://purl.obolibrary.org/obo/HP_0004808"},{"id":"A347","pred":"hp_id","subj":"T347","obj":"http://purl.obolibrary.org/obo/HP_0002863"},{"id":"A348","pred":"hp_id","subj":"T348","obj":"http://purl.obolibrary.org/obo/HP_0005505"},{"id":"A349","pred":"hp_id","subj":"T349","obj":"http://purl.obolibrary.org/obo/HP_0004808"},{"id":"A350","pred":"hp_id","subj":"T350","obj":"http://purl.obolibrary.org/obo/HP_0004808"},{"id":"A351","pred":"hp_id","subj":"T351","obj":"http://purl.obolibrary.org/obo/HP_0012325"}],"text":"Cases were subclassified into primary myelofibrosis (PMF), n=4; refractory cytopenia with multilineage dysplasia, n=3; acute myeloid leukemia (AML) with myelodysplasia-related changes, n=3; refractory anemia with excess blasts-2, n=1; AML-not otherwise specified, n=1; therapy-related AML, n=1; blast phase of PMF, n=1; and chronic myelomonocytic leukemia, n=1."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T813","span":{"begin":30,"end":51},"obj":"Disease"},{"id":"T814","span":{"begin":38,"end":51},"obj":"Disease"},{"id":"T815","span":{"begin":53,"end":56},"obj":"Disease"},{"id":"T816","span":{"begin":64,"end":112},"obj":"Disease"},{"id":"T817","span":{"begin":119,"end":147},"obj":"Disease"},{"id":"T819","span":{"begin":119,"end":141},"obj":"Disease"},{"id":"T820","span":{"begin":125,"end":141},"obj":"Disease"},{"id":"T821","span":{"begin":133,"end":141},"obj":"Disease"},{"id":"T822","span":{"begin":143,"end":146},"obj":"Disease"},{"id":"T823","span":{"begin":153,"end":167},"obj":"Disease"},{"id":"T824","span":{"begin":190,"end":226},"obj":"Disease"},{"id":"T825","span":{"begin":190,"end":207},"obj":"Disease"},{"id":"T826","span":{"begin":201,"end":207},"obj":"Disease"},{"id":"T827","span":{"begin":235,"end":238},"obj":"Disease"},{"id":"T829","span":{"begin":285,"end":288},"obj":"Disease"},{"id":"T831","span":{"begin":295,"end":306},"obj":"Disease"},{"id":"T832","span":{"begin":310,"end":313},"obj":"Disease"},{"id":"T833","span":{"begin":324,"end":355},"obj":"Disease"},{"id":"T835","span":{"begin":347,"end":355},"obj":"Disease"},{"id":"T69126","span":{"begin":30,"end":51},"obj":"Disease"},{"id":"T94328","span":{"begin":38,"end":51},"obj":"Disease"},{"id":"T19171","span":{"begin":53,"end":56},"obj":"Disease"},{"id":"T21860","span":{"begin":64,"end":112},"obj":"Disease"},{"id":"T35431","span":{"begin":119,"end":147},"obj":"Disease"},{"id":"T810","span":{"begin":119,"end":141},"obj":"Disease"},{"id":"T33223","span":{"begin":125,"end":141},"obj":"Disease"},{"id":"T16423","span":{"begin":133,"end":141},"obj":"Disease"},{"id":"T31040","span":{"begin":143,"end":146},"obj":"Disease"},{"id":"T49187","span":{"begin":153,"end":167},"obj":"Disease"},{"id":"T29225","span":{"begin":190,"end":226},"obj":"Disease"},{"id":"T39754","span":{"begin":190,"end":207},"obj":"Disease"},{"id":"T31544","span":{"begin":201,"end":207},"obj":"Disease"},{"id":"T818","span":{"begin":235,"end":238},"obj":"Disease"},{"id":"T20532","span":{"begin":285,"end":288},"obj":"Disease"},{"id":"T64414","span":{"begin":295,"end":306},"obj":"Disease"},{"id":"T78268","span":{"begin":310,"end":313},"obj":"Disease"},{"id":"T84388","span":{"begin":324,"end":355},"obj":"Disease"},{"id":"T16237","span":{"begin":347,"end":355},"obj":"Disease"}],"attributes":[{"id":"A813","pred":"mondo_id","subj":"T813","obj":"http://purl.obolibrary.org/obo/MONDO_0009692"},{"id":"A814","pred":"mondo_id","subj":"T814","obj":"http://purl.obolibrary.org/obo/MONDO_0044903"},{"id":"A815","pred":"mondo_id","subj":"T815","obj":"http://purl.obolibrary.org/obo/MONDO_0009692"},{"id":"A816","pred":"mondo_id","subj":"T816","obj":"http://purl.obolibrary.org/obo/MONDO_0019453"},{"id":"A817","pred":"mondo_id","subj":"T817","obj":"http://purl.obolibrary.org/obo/MONDO_0004996"},{"id":"A818","pred":"mondo_id","subj":"T817","obj":"http://purl.obolibrary.org/obo/MONDO_0018874"},{"id":"A819","pred":"mondo_id","subj":"T819","obj":"http://purl.obolibrary.org/obo/MONDO_0015667"},{"id":"A820","pred":"mondo_id","subj":"T820","obj":"http://purl.obolibrary.org/obo/MONDO_0004643"},{"id":"A821","pred":"mondo_id","subj":"T821","obj":"http://purl.obolibrary.org/obo/MONDO_0005059"},{"id":"A822","pred":"mondo_id","subj":"T822","obj":"http://purl.obolibrary.org/obo/MONDO_0015667"},{"id":"A823","pred":"mondo_id","subj":"T823","obj":"http://purl.obolibrary.org/obo/MONDO_0018881"},{"id":"A824","pred":"mondo_id","subj":"T824","obj":"http://purl.obolibrary.org/obo/MONDO_0019454"},{"id":"A825","pred":"mondo_id","subj":"T825","obj":"http://purl.obolibrary.org/obo/MONDO_0005272"},{"id":"A826","pred":"mondo_id","subj":"T826","obj":"http://purl.obolibrary.org/obo/MONDO_0002280"},{"id":"A827","pred":"mondo_id","subj":"T827","obj":"http://purl.obolibrary.org/obo/MONDO_0018874"},{"id":"A828","pred":"mondo_id","subj":"T827","obj":"http://purl.obolibrary.org/obo/MONDO_0015667"},{"id":"A829","pred":"mondo_id","subj":"T829","obj":"http://purl.obolibrary.org/obo/MONDO_0018874"},{"id":"A830","pred":"mondo_id","subj":"T829","obj":"http://purl.obolibrary.org/obo/MONDO_0015667"},{"id":"A831","pred":"mondo_id","subj":"T831","obj":"http://purl.obolibrary.org/obo/MONDO_0006115"},{"id":"A832","pred":"mondo_id","subj":"T832","obj":"http://purl.obolibrary.org/obo/MONDO_0009692"},{"id":"A833","pred":"mondo_id","subj":"T833","obj":"http://purl.obolibrary.org/obo/MONDO_0011908"},{"id":"A834","pred":"mondo_id","subj":"T833","obj":"http://purl.obolibrary.org/obo/MONDO_0020311"},{"id":"A835","pred":"mondo_id","subj":"T835","obj":"http://purl.obolibrary.org/obo/MONDO_0005059"},{"id":"A41371","pred":"mondo_id","subj":"T69126","obj":"http://purl.obolibrary.org/obo/MONDO_0009692"},{"id":"A16458","pred":"mondo_id","subj":"T94328","obj":"http://purl.obolibrary.org/obo/MONDO_0044903"},{"id":"A10447","pred":"mondo_id","subj":"T19171","obj":"http://purl.obolibrary.org/obo/MONDO_0009692"},{"id":"A95851","pred":"mondo_id","subj":"T21860","obj":"http://purl.obolibrary.org/obo/MONDO_0019453"},{"id":"A63457","pred":"mondo_id","subj":"T35431","obj":"http://purl.obolibrary.org/obo/MONDO_0004996"},{"id":"A7715","pred":"mondo_id","subj":"T35431","obj":"http://purl.obolibrary.org/obo/MONDO_0018874"},{"id":"A5239","pred":"mondo_id","subj":"T810","obj":"http://purl.obolibrary.org/obo/MONDO_0015667"},{"id":"A38040","pred":"mondo_id","subj":"T33223","obj":"http://purl.obolibrary.org/obo/MONDO_0004643"},{"id":"A79067","pred":"mondo_id","subj":"T16423","obj":"http://purl.obolibrary.org/obo/MONDO_0005059"},{"id":"A6824","pred":"mondo_id","subj":"T31040","obj":"http://purl.obolibrary.org/obo/MONDO_0015667"},{"id":"A24762","pred":"mondo_id","subj":"T49187","obj":"http://purl.obolibrary.org/obo/MONDO_0018881"},{"id":"A7171","pred":"mondo_id","subj":"T29225","obj":"http://purl.obolibrary.org/obo/MONDO_0019454"},{"id":"A99225","pred":"mondo_id","subj":"T39754","obj":"http://purl.obolibrary.org/obo/MONDO_0005272"},{"id":"A52275","pred":"mondo_id","subj":"T31544","obj":"http://purl.obolibrary.org/obo/MONDO_0002280"},{"id":"A21798","pred":"mondo_id","subj":"T818","obj":"http://purl.obolibrary.org/obo/MONDO_0018874"},{"id":"A91340","pred":"mondo_id","subj":"T818","obj":"http://purl.obolibrary.org/obo/MONDO_0015667"},{"id":"A96009","pred":"mondo_id","subj":"T20532","obj":"http://purl.obolibrary.org/obo/MONDO_0018874"},{"id":"A30574","pred":"mondo_id","subj":"T20532","obj":"http://purl.obolibrary.org/obo/MONDO_0015667"},{"id":"A37554","pred":"mondo_id","subj":"T64414","obj":"http://purl.obolibrary.org/obo/MONDO_0006115"},{"id":"A68309","pred":"mondo_id","subj":"T78268","obj":"http://purl.obolibrary.org/obo/MONDO_0009692"},{"id":"A4973","pred":"mondo_id","subj":"T84388","obj":"http://purl.obolibrary.org/obo/MONDO_0011908"},{"id":"A26026","pred":"mondo_id","subj":"T84388","obj":"http://purl.obolibrary.org/obo/MONDO_0020311"},{"id":"A63107","pred":"mondo_id","subj":"T16237","obj":"http://purl.obolibrary.org/obo/MONDO_0005059"}],"text":"Cases were subclassified into primary myelofibrosis (PMF), n=4; refractory cytopenia with multilineage dysplasia, n=3; acute myeloid leukemia (AML) with myelodysplasia-related changes, n=3; refractory anemia with excess blasts-2, n=1; AML-not otherwise specified, n=1; therapy-related AML, n=1; blast phase of PMF, n=1; and chronic myelomonocytic leukemia, n=1."}